Literature DB >> 12505521

Innate immunity to cytomegalovirus: the Cmv1 locus and its role in natural killer cell function.

Seung Hwan Lee1, John R Webb, Silvia M Vidal.   

Abstract

The identification and characterization of genetic loci that contribute to patterns of susceptibility/resistance to infection provide important insights into the mechanisms of innate and adaptive immunity. Genetic heterogeneity across the population makes the characterization of such traits in humans technically difficult; however, inbred animal models represent an ideal tool for such analyses. This review illustrates the power of mouse genetics as utilized for the identification and characterization of the locus conferring early resistance to murine cytomegalovirus infection, Cmv1. This locus encodes an activating C-type lectin receptor of the Ly49 family that promotes natural killer (NK) cell cytolysis of infected cells. Although NK cells are usually able to detect and destroy virally infected cells via recognition of the downregulation of MHC class I molecules, the Cmv1 locus provides the first example of an NK receptor that is able to mediate clearance of viral infection via direct recognition of a virally encoded protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505521     DOI: 10.1016/s1286-4579(02)00032-1

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  6 in total

1.  Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.

Authors:  Christopher S Morello; Ming Ye; Stephanie Hung; Laura A Kelley; Deborah H Spector
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver.

Authors:  Joy Loh; Dortha T Chu; Andrew K O'Guin; Wayne M Yokoyama; Herbert W Virgin
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells.

Authors:  Valentina Voigt; Catherine A Forbes; Joanne N Tonkin; Mariapia A Degli-Esposti; Hamish R C Smith; Wayne M Yokoyama; Anthony A Scalzo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 4.  The impact of Ly49-NK cell-dependent recognition of MCMV infection on innate and adaptive immune responses.

Authors:  Michal Pyzik; Eve-Marie Gendron-Pontbriand; Silvia M Vidal
Journal:  J Biomed Biotechnol       Date:  2011-05-22

5.  Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes.

Authors:  Geoffrey O Gillard; Maytal Bivas-Benita; Avi-Hai Hovav; Lauren E Grandpre; Michael W Panas; Michael S Seaman; Barton F Haynes; Norman L Letvin
Journal:  PLoS Pathog       Date:  2011-08-04       Impact factor: 6.823

6.  CD13/aminopeptidase N and murine cytomegalovirus infection.

Authors:  Laura M Kasman
Journal:  Virology       Date:  2005-03-30       Impact factor: 3.616

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.